Unique ID issued by UMIN | UMIN000043278 |
---|---|
Receipt number | R000049401 |
Scientific Title | Effect of the combined ingestion of plant-derived ingredients on the pharmacokinetic parameter |
Date of disclosure of the study information | 2021/02/08 |
Last modified on | 2021/02/08 14:48:24 |
Effect of the combined ingestion of plant-derived ingredients on the pharmacokinetic parameter
Effect of the combined ingestion of plant-derived ingredients on the pharmacokinetic parameter
Effect of the combined ingestion of plant-derived ingredients on the pharmacokinetic parameter
Effect of the combined ingestion of plant-derived ingredients on the pharmacokinetic parameter
Japan |
Healthy adults
Not applicable | Adult |
Others
NO
To evaluate the dose-response effect of the ingredients on the pharmacokinetic parameter
Bio-availability
Evaluation of the pharmacokinetic parameter after the single ingestion.
(AUC)
Evaluation of the pharmacokinetic parameter after the single ingestion.
(Cmax, Tmax)
Interventional
Cross-over
Randomized
Individual
Single blind -investigator(s) and assessor(s) are blinded
Dose comparison
5
Treatment
Food |
control (1) > wash out > control (2) > wash out > test beverage (1) > wash out > test beverage (2) > wash out > test beverage (3)
control (2) > wash out > test beverage (2) > wash out > test beverage (3) > wash out > test beverage (1) > wash out > control (1)
test beverage (1) > wash out > test beverage (3) > wash out > control (2) > wash out > control (1) > wash out > test beverage (2)
test beverage (2) > wash out > test beverage (1) > wash out > control (1) > wash out > test beverage (3) > wash out > control (2)
test beverage (3) > wash out > control (1) > wash out > test beverage (2) > wash out > control (2) > test beverage (1)
20 | years-old | <= |
59 | years-old | >= |
Male
Healthy males
BMI <= 18.5 and >= 29.9
1) history of or under treatment for gastrointestinal disorder
2) under treatment for severe disease
3) taking therapeutic medicine
4) TG > 399mg/dL, T-Cho > 259mg/dL, FBG 125mg/dL > and HbA1c > 6.4%, AST > 50U/L, ALT > 50U/L, g-GTP > 100U/L
5) HBs positive, HCV positive
6) creatinine > 1.29mg/dL, BUN > 22.0mg/dL
7) syphilis positive, HIV positive
8) food allergy
9) shift worker
10) blood donor (> 200 mL within the last month or > 400 mL within the last 3 months)
11) heavy drinker
12) heavy smoker
13) drinking less than 2 cups of tea or coffee per day
14) Subjects who are judged to be inappropriate for the study by the medical doctor
8
1st name | Masanobu |
Middle name | |
Last name | Hibi |
Kao Corporation
Biological Science Research
131-8501
2-1-3, Bunka, Sumida-ku, Tokyo 131-8501, Japan
+81-3-5630-7266
hibi.masanobu@kao.com
1st name | Sachiko |
Middle name | |
Last name | Oishi |
Kao Corporation
Biological Science Research
131-8501
2-1-3, Bunka, Sumida-ku, Tokyo 131-8501, Japan
+81-3-5630-7266
oishi.sachiko@kao.com
Kao Corporation
Kao Corporation
Profit organization
Japan Conference of Clinical Research
2-27-17 Minami-ikebukuro, toshima-ku, Tokyo, 171-0022, Japan
03-6868-7022
kakigi@3h-ms.co.jp
NO
医療法人社団成守会 成守会クリニック(東京都)
2021 | Year | 02 | Month | 08 | Day |
Unpublished
8
Completed
2016 | Year | 04 | Month | 23 | Day |
2016 | Year | 04 | Month | 23 | Day |
2016 | Year | 04 | Month | 23 | Day |
2021 | Year | 01 | Month | 31 | Day |
2021 | Year | 02 | Month | 08 | Day |
2021 | Year | 02 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049401